Pancreatic Tumor
Links shared publicly online about this topic
Breaking Down Pancreatic Tumor Defenses
nih.gov — “A new approach for attacking pancreatic tumors may lead to improved therapy for patients with inoperable disease, scientists report. The strategy offers hope for more effective techniques to eliminate tumors.” View full resource at nih.gov
Most Recently Shared on April 4, 2011 at 8:38 pm By:
First Use Of Innovative "IRE" On Pancreatic Tumor
medicalnewstoday.com — “A new procedure for treating pancreatic and liver cancers using electrical fields to poke holes in tumors was used for the first time anywhere to fight pancreatic cancer at Stony Brook University” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2010 at 6:13 pm By:
MNT Gastrointestinal Health News
First Use Of Innovative "IRE" On Pancreatic Tumor http://mnt.to/3yx9 #gastrointestinal
Locating Rare Pancreatic Tumors With New Imaging Technique
medicalnewstoday.com — “A non-invasive way to detect the exact location of very small life-threatening tumors in the pancreas (insulinomas) has been discovered by a team of researchers in Switzerland. This new techn” View full resource at medicalnewstoday.com
Most Recently Shared on May 9, 2012 at 5:05 pm By:
Locating Rare Pancreatic Tumors With New Imaging Technique http://t.co/WgX6HXtL #cancer
Role In Suppressing Pancreatic Tumors Played By Protein Complex
medicalnewstoday.com — “A well-known protein complex responsible for controlling how DNA is expressed plays a previously unsuspected role in preventing pancreatic cancer, according to researchers at the Stanford Universi” View full resource at medicalnewstoday.com
Most Recently Shared on January 10, 2012 at 12:06 pm By:
MNT Pancreatic Can Health News
Role In Suppressing Pancreatic Tumors Played By Protein Complex http://t.co/PMJuaJ5l #pancreaticcancer
Autoimmune response can induce pancreatic tumor rejection
physorg.com — “Immune responses are capable of killing tumors before they can be directed toward normal body tissue, according to new scientific findings published in Cancer Research, a journal of the American Association for Cancer Research.” View full resource at physorg.com
Most Recently Shared on September 8, 2009 at 7:22 pm By:
Autoimmune response can induce pancreatic tumor rejection http://bit.ly/Y5GrG
Symposier - MDCT /CTA Evaluation of Pancreatic Tumors
symposier.com — “Uploaded and shared in Youtube by: ctisus " MDCT /CTA Evaluation of Pancreatic Tumors” View full resource at symposier.com
Most Recently Shared on September 14, 2010 at 12:38 am By:
Symposier Endocrino Health Site
MDCT /CTA Evaluation of Pancreatic Tumors. http://bit.ly/cBvd89
Sutent Gains Indication for Advanced Pancreatic Tumors - ONA
oncologynurseadvisor.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 23, 2011 at 2:50 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Sutent Gains Indication for Advanced Pancreatic Tumors http://goo.gl/fb/AhvBJ
Sutent Gains Indication for Advanced Pancreatic Tumors - MPR
empr.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on May 23, 2011 at 2:35 pm By:
MPR News: Sutent Gains Indication for Advanced Pancreatic Tumors: The FDA has approved Sutent (sunitinib malate;... http://bit.ly/klWR8Y
Pfizer Drug Slows Pancreatic Tumors in New Attack on Cancer - Businessweek
businessweek.com — “An experimental drug made by Pfizer Inc. slowed deadly pancreatic cancer in a study that revealed a new treatment approach that tricks the immune system to attack tissue protecting tumors, researchers said.” View full resource at businessweek.com
Most Recently Shared on March 25, 2011 at 12:11 pm By:
John Carroll Health Communicator
Pfizer's CP- 870,893 immunotherapy looks promising against pancreatic cancer. http://buswk.co/gvaBMO
FDA panel OKs Novartis' pancreatic tumor drug - Forbes.com
forbes.com — “FDA panel OKs Novartis' pancreatic tumor drug - Forbes.com” View full resource at forbes.com
Most Recently Shared on May 6, 2011 at 1:37 am By:
Thomas J Reid MD PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Affinitor approved for pancreatic NE tumors. http://www.forbes.com/feeds/ap/2011/05/05/business-health-care-us-novartis-fda_8452780.html
Whole Genome Sequencing Used To Help Inform Deadly Pancreatic Tumor Therapy
medicalnewstoday.com — “Whole genome sequencing - spelling out a person's entire DNA genetic code - has moved one step closer to being a medical option for direct patient care.Physicians and researchers at Mayo” View full resource at medicalnewstoday.com
Most Recently Shared on February 17, 2011 at 1:05 pm By:
Whole Genome Sequencing Used To Help Inform Deadly Pancreatic Tumor Therapy http://mnt.to/3RfF #primarycare
A New Way to Get Chemo to Pancreatic Tumors - myOptumHealth
myoptumhealth.com — “Read the news article A New Way to Get Chemo to Pancreatic Tumors at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on May 22, 2009 at 1:02 am By:
A New Way to Get Chemo to Pancreatic Tumors: Technique that doubles life span in mice may hold hope for people http://tinyurl.com/qth4ln
PharmaLive: FDA Panel Oks Novartis' Pancreatic Tumor Drug
pharmalive.com — “PharmaLive: FDA Panel Oks Novartis' Pancreatic Tumor Drug” View full resource at pharmalive.com
Most Recently Shared on May 6, 2011 at 8:11 pm By:
PharmaLive Pharma and Health News
Daily Advantage - FDA Panel OKs Novartis' Pancreatic Tumor Drug - http://tinyurl.com/42xzvpa
Blood-flow Metabolism Mismatch Predicts Pancreatic Tumor Aggressiveness
sciencedaily.com — “Researchers from Finland have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a new study.” View full resource at sciencedaily.com
Most Recently Shared on August 26, 2009 at 10:41 pm By:
Blood-flow Metabolism Mismatch Predicts Pancreatic Tumor Aggressiveness http://ow.ly/15MyHr
FDA panel OKs Novartis pancreatic tumor drug | Pharmaceutical Processing
pharmpro.com — “FDA panel approves Novartis AG drug for treating advanced tumors in pancreas” View full resource at pharmpro.com
Most Recently Shared on May 6, 2011 at 12:32 pm By:
RT @PharmProEditor: #FDA panel OKs Novartis' pancreatic tumor drug http://bit.ly/mwdj4Y
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Dawn McKinney, MS/RN
RN/Nursing Educator; consultant. Interests include peds neuro & psych, including genetics. Former Navy LCDR with varied acute care experience.
-
MNT Gastrointestinal
The latest gastrointestinal news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Cancer News
The latest cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
